ach year, 230,000 women in the United States are diagnosed with invasive breast cancer.
Background:
The BREAST-Q is a patient-reported outcome instrument used to evaluate outcomes in patients undergoing breast cancer surgery and reconstruction. Normative values for the BREAST-Q breast cancer modules have not been established, limiting data interpretation. Methods: Participants were recruited by means of the Army of Women, an online community of women (with and without breast cancer), to complete Mastectomy, Breast Conserving Therapy, and Reconstruction preoperative BREAST-Q scales. Inclusion criteria were women aged 18 years or older without a history of breast surgery or breast cancer. Analysis included descriptive statistics, a linear multivariate regression, and a comparison of the generated normative data to previously published BREAST-Q findings. Results: The BREAST-Q was completed by 1201 women. The mean patient age was 54 ± 13 years, mean body mass index 26 ± 6 kg/m 2 , and 38 percent (n = 455) had a bra cup size of D or greater. Mean ± SD scores for BREAST-Q scales were as follows: Satisfaction with Breasts (58 ± 18), Psychosocial Wellbeing (71 ± 18), Sexual Well-being (56 ± 18), Physical Well-being-Chest (93 ± 11), and Physical Well-being Abdomen (78 ± 20). Women with a body mass index of 30 kg/m 2 or greater, cup size of D or greater, age younger than 40 years, and annual income less than $40,000 reported lower scores. Comparing normative scores to published data in breast cancer patients, Satisfaction with Breasts scores were higher after autologous reconstruction and lower after mastectomy; Sexual Well-being scores were lower after mastectomy and breast conserving therapy; and Physical Well-being Chest scores were lower after mastectomy, breast conserving therapy, and reconstruction. Conclusion: These are the first published normative scores for the BREAST-Q breast cancer modules and provide a clinical reference point for the interpretation of data. (Plast. Reconstr. Surg. 139: 1046e, 2017.)
The BREAST-Q is a validated, rigorously developed patient-reported outcome instrument specific to breast surgery. The BREAST-Q has been used in over 22,000 patients undergoing breast surgery, including breast reconstruction, augmentation, and reduction. [9] [10] [11] [12] [13] [14] Relevant to breast cancer, there are BREAST-Q modules specific to mastectomy, breast conserving therapy, and breast reconstruction. Each module has preoperative and postoperative scales. There are four scales common to all preoperative modules for breast cancer and reconstruction patients: Satisfaction with Breasts, Psychosocial Well-being, Sexual Wellbeing, and Physical Well-being. The Reconstruction module also has Physical Well-being Abdomen for use in autologous reconstruction patients. Each scale is scored to generate a numeric score on a scale from 0 (worst) to 100 (best), which can then be used to compare patients undergoing different procedures or at different preoperative and postoperative time points. The BREAST-Q has been in use since its inception in 2009 and has led to important findings related to breast surgery.
A current limitation of the BREAST-Q is a lack of normative values. It is not yet known how patients who are presenting for and undergoing breast cancer resection and reconstruction compare to a population control. This limits both our interpretation of BREAST-Q data and our ability to fully qualify the impact of breast cancer and breast reconstruction on individuals. The primary aim of this study was to determine population norms for the BREAST-Q Reconstruction module. These normative values will be applicable to the Mastectomy, Breast Conserving Therapy, and Reconstruction modules. The secondary aim was to compare these generated population norms to previously published findings describing outcomes in women undergoing breast cancer treatment and reconstruction.
PATIENTS AND METHODS

Study Population
Participants were recruited by means of the Army of Women, an online community of women, with and without breast cancer, started in 2008 by the Dr. Susan Love Research Foundation, with a mission to promote breast cancer research. Inclusion criteria were female sex, age 18 years or older, no history of breast cancer or breast surgery, and the ability to complete an online questionnaire in English. Before recruitment, the study was accepted by the Scientific Advisory Committee at the Army of Women, and Dartmouth College's Committee for the Protection of Human Subjects granted an institutional review board waiver.
Recruitment
An electronic recruitment e-mail (e-blast) was sent to 121,688 Army of Women members with a short description of the study and the eligibility stated above. Army of Women members interested in participating self-selected to complete the study based on the inclusion criteria. Data were collected using Qualtrics, a Web-based software for questionnaire administration (Provo, Utah; www. qualtrics.com). Recruitment was part of a larger study to generate normative scores for the breast cancer (Mastectomy, Breast Conserving Therapy, and Reconstruction), Augmentation, and Reduction BREAST-Q modules. Participants completed one of the three BREAST-Q modules along with demographic information, bra cup size, height, and weight. Participants did not know which BREAST-Q module was being completed. Data collection for the three modules was completed in a stepwise fashion, with an algorithm in the e-blast hyperlink automatically rerouting participants to the next BREAST-Q module once 1200 participants had completed the prior module. Normative values for the Reduction and Augmentation modules will be published separately.
BREAST-Q
The BREAST-Q is a rigorously developed, wellvalidated, breast surgery-specific, patient-reported outcome instrument that has been administered to over 22,000 women, making it one of the most widely used breast surgery-specific patientreported outcome instruments. [9] [10] [11] [12] [13] [14] [15] Published in 2009 following internationally accepted guidelines for patient-reported outcome development, the BREAST-Q has modules designed specifically for the evaluation of outcomes in women undergoing mastectomy, breast conserving therapy, and breast reconstruction. 9, 11, 16, 17 The conceptual framework and set of scales were developed from a literature review, patient interviews (n = 48), cognitive patient interviews (n = 46), and expert opinion from health care professionals, including plastic surgeons. Before publication of the finalized instrument, the BREAST-Q was administered to 2715 patients, including 908 presurgery patients and 1807 postsurgery patients. The Reconstruction module had Cronbach's alpha scores of 0.88 to 0.96, item total correlations of 0.56 to 0.86, and test-retest reliability with intraclass correlation coefficients of 0.93 to 0.96. The BREAST-Q breast cancer modules have four preoperative scales: Satisfaction with Breasts (n = 4 items), Psychosocial Well-being (n = 10 items), Sexual Well-being (n = 6 items), and Physical Well-being Chest (n = 16 items), and the Reconstructive preoperative module also has Physical Well-being Abdomen (n = 5 items). Responses on each scale are summed and then transformed using Q-Score (New York, N.Y.; https://webcore. mskcc.org/breastq/scoring.html) to a scale from 0 (worst) to 100 (best).
Statistical Analysis
Data analysis included descriptive statistics and a backward-selection linear multivariate regression to identify which variables were associated with BREAST-Q scores. Computed descriptive statistics included mean, standard deviation, 95 percent confidence intervals for continuous variables, and percentages for categorical variables. Continuous and categorical nondichotomous variables were transformed into dichotomous variables for the multivariate regression analysis as follows: body mass index, greater than or equal to 30 versus less than 30; age, 40 years or older versus younger than 40 years; bra cup size, greater than or equal to D versus less than D; ethnicity, white non-Hispanic versus all others; education, college degree or higher versus less than college degree; employment, full-time versus other than full-time; income, $40,000 or more versus less than $40,000 per year; and marital status, married (including living with significant other) versus other. Binomial variables with a probability of less than 0.2 were rejected and removed from the model, and the model was rerun with only significant variables (p < 0.05) included. Data analysis was performed using Stata/SE 11.0 (StataCorp, College Station, Texas).
Using the Army of Women normative data generated in this study, a separate descriptive analysis compared these data to previously published BREAST-Q data. Studies were identified by a literature search in July of 2016 in PubMed, with "BREAST-Q" and "BREASTQ" as search terms. Identified studies were evaluated manually for use of the Mastectomy, Breast Conserving Therapy, and Reconstruction modules. Data extracted from each publication included study design, sample size, and BREAST-Q scores, with sample size and BREAST-Q mean score and standard deviation used to calculate a 95 percent confidence interval. Additional information was requested from authors as needed. There are no published guidelines regarding minimal clinically important differences for the BREAST-Q Reconstruction module. A difference of 0.5 SD was used for the BREAST-Q Augmentation module, 18 and thus we adopted a difference of 0.5 SD of our normative scores, for analyzing the differences between normative scores and published data.
There were 74 identified studies using the BREAST-Q Reconstruction module for evaluating outcomes in women undergoing mastectomy, breast conserving therapy, and/or reconstruction. There were no published studies with available data specifying use of either the Mastectomy or the Breast Conserving Therapy module; rather, the BREAST-Q Reconstruction module was used to capture outcomes in these patients. Studies were selected that had large sample sizes, with authors contacted for missing data. To compare outcomes in patients after mastectomy, a recent study by Ng et al. reporting on 79 postmastectomy patients was selected. 19 To compare findings after breast conserving therapy, a study by Howes et al. describing postoperative findings at a mean postoperative time of 2.4 years after breast conserving therapy (n = 97) was selected. 20 Data from the Mastectomy Reconstruction Outcomes Consortium Study was selected for reconstruction patients. Preoperative (n = 1996) and 1-year postoperative (n = 1688) data in women with implant reconstruction, and preoperative (n = 950) and 1-year postoperative (n = 809) data in women with autologous reconstruction, were reported.
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RESulTS
The e-blast was circulated to the 121,688 active Army of Women members in August of 2015. To recruit the remaining 409 participants to complete 3600 participants across all three BREAST-Q modules, a second e-blast was circulated in November of 2015. A total of 4326 women self-selected to meet inclusion criteria, and 3618 women completed one of the three preoperative BREAST-Q modules. After meeting capacity, an additional 142 women attempted to complete the study before the study closed by means of the Army of Women. The total response rate was 87 percent, with 1201 of the participants completing the preoperative breast cancer modules.
Specific to the breast cancer and reconstruction sample, mean age was 54 ±13 years, mean body mass index was 26 ± 6 kg/m 2 , and 38 percent had a bra cup size of D or greater (n = 455). The majority of participants were non-Hispanic white [n = 1097 (92 percent)]. In addition, 818 (68 percent) were married. The full demographic data are listed in Table 1 . Normative scores are listed in Table 2 . Of note, 85 percent of participants (n = 1018) completed the Sexual Well-being instrument. Consistent with instructions in the BREAST-Q based on patient feedback, study participants were specifically instructed not to complete items in the Sexual Well-being scale if they felt the content was not applicable to them, or they felt uncomfortable with the subject matter.
Using 95 percent confidence intervals, the linear multivariate regression was used to identify variables (i.e., age, body mass index, bra cup size, income, and marital status) across the five breast cancer scales associated with BREAST-Q scores (Fig. 1) . Women with a body mass index greater than or equal to 30, bra cup size greater than or equal to D, age younger than 40 years, and income less than $40,000 per year had lower scores for the breast cancer modules compared with a reference group of women without those demographic and body size variables.
The comparison between the previously published mastectomy and breast conserving therapy data and normative BREAST-Q scores using 95 percent confidence intervals are shown in Figs The comparison between the preoperative and 1-year postoperative Mastectomy Reconstruction Outcomes Consortium data and normative BREAST-Q scores using 95 percent confidence intervals are demonstrated in Fig. 4 . Physical Wellbeing Chest scores were lower than normative values in the preoperative and postoperative groups for autologous and implant-based reconstruction. Higher postoperative scores were reported for Satisfaction with Breasts both in comparison to preoperative values and the Army of Women normative scores after autologous reconstruction. Autologous reconstruction was also associated with an increase in Psychosocial Well-being and a decrease in Physical Well-being Abdomen between preoperative and postoperative patients.
DISCuSSION
Breast cancer has the highest incidence of any cancer in the United States, although fortunately with a comparatively low mortality rate. 22 In the setting of lower mortality, issues of satisfaction and quality of life are of increased importance in evaluating outcomes in this population. To this end, patient-reported outcome questionnaires, such as the BREAST-Q, that capture the impact of breast cancer surgery and reconstruction on breast-related satisfaction and quality of life play a key role in helping to understand the burden of disease and in shaping clinical practice. Since inception in 2009, the BREAST-Q has been used to demonstrate many key findings in this patient population.
The BREAST-Q has shown the impact of breast reconstruction on patient-reported outcomes and the value of reconstruction after mastectomy. In one of the earliest studies using the BREAST-Q to examine the differences in patient-reported outcomes between women undergoing mastectomy alone versus reconstruction, Eltahir et al. demonstrated lower BREAST-Q scores for Satisfaction with Breasts, Psychosocial Well-being, and Sexual Well-being in women after mastectomy alone versus mastectomy with reconstruction. 23 These findings have been replicated in multiple subsequent studies, 19, 20, 24, 25 including a prospective study by Chao et al. that demonstrated lower Satisfaction with Breasts, Psychosocial Well-being, Sexual Wellbeing, and Physical Well-being Chest in patients undergoing mastectomy alone versus mastectomy with reconstruction. 26 Although BREAST-Q outcomes following breast conserving therapy are not as well established, Satisfaction with Breasts scores after breast conserving therapy with various incision techniques have been reported, along with findings of higher scores associated with lower quantities of resected tissue and scores associated with breast conserving therapy lower than reconstruction yet higher than mastectomy alone. 20, [27] [28] [29] In patients who undergo reconstruction, autologous reconstruction has been associated with higher Satisfaction with Breasts, Psychosocial Well-being, and Physical Well-being in comparison with implant-based reconstruction. [30] [31] [32] [33] [34] In addition, in implant-based reconstruction, the BREAST-Q has been used to demonstrate superior patient-reported outcome scores when using silicone in comparison with saline implants for reconstructive and cosmetic augmentation purposes. [35] [36] [37] [38] The findings discussed above are important, and many have impacted patterns of care and third-party reimbursement. However, a key limitation to the current literature is how women not undergoing breast cancer treatment or breast reconstruction report breast satisfaction and breast-related quality of life. The normative data generated here provide clinical context and a reference point to interpreting BREAST-Q scores going forward.
In the literature, patients undergoing mastectomy alone have been shown to have lower BREAST-Q scores for all four preoperative scales (i.e., Satisfaction with Breasts, Psychosocial Well-being, Sexual Well-being, and Physical Well-being) compared with women after reconstruction. 19, 20, [23] [24] [25] [26] In the data published by Ng et al., Psychosocial Well-being is not less than 0.5 SD below the norm. 19 This finding suggests that although mastectomy alone may impact psychosocial well-being in a negative way, these women do not report lower levels of overall emotional wellness, self-confidence, and/or body acceptance in comparison to a normative population.
In the data published by Howes et al., BREAST-Q scores were highest in those women undergoing reconstruction, followed by breast conserving therapy, and then mastectomy alone. 20 When comparing the reported breast conserving therapy scores to normative data, only Sexual Well-being and Physical Well-being Chest are lower than 0.5 SD below the norm. This suggests that although overall women may be less satisfied with breast conserving therapy in comparison with mastectomy with reconstruction, this is of most clinical relevance when discussing sexual and physical well-being.
The literature has demonstrated that women who undergo autologous reconstruction have improved satisfaction and quality of life compared with women who undergo implant-based reconstruction. 30, 32, 33 The normative values generated here provide increased clinical relevance to this finding. In the Mastectomy Reconstruction Outcomes Consortium study, only patients with autologous reconstruction had Satisfaction with Breasts scores above the norm, suggesting that the other differences between autologous and implant-based reconstruction may not be of the same clinical relevance. However, perhaps of greater importance, the Mastectomy Reconstruction Outcomes Consortium data also demonstrate that both implant and autologous breast reconstruction are associated with postoperative scores at or above the normative level. Having a normative reference point gives greater meaning to changes in the BREAST-Q than purely the comparison of preoperative and postoperative data points. Preoperative patients are not "normal," as they have undergone the physical and psychological trauma associated with being diagnosed with breast cancer, changes captured in the BREAST-Q. Breast reconstruction can now be associated with a "return to normalcy," a clinically relevant finding, and a finding that mastectomy alone has not demonstrated.
Women in all three studies used for comparison had Physical Well-being scores below the norm. Preoperative scores may be explained by pain secondary to the tumor itself, or pain after biopsy before cancer resection. Postoperative scores may be explained by a multitude of factors, including the resulting scar, damage to the pectoralis major muscle, capsular contracture, and physical limitations after breast surgery or reconstruction.
Within our normative population, there were factors associated with differences in generated normative BREAST-Q scores. Women with a larger body mass index and bra cup size had lower breast satisfaction and breast-related quality of life. Alternatively, women who were older had higher breast satisfaction and breast-related quality of life. These factors may impact the interpretation of normative values in these patient populations.
This study has several advantages. This is the first study to generate normative values for the BREAST-Q Reconstructive module. These normative scores may be used for the Satisfaction with Breasts, Psychosocial Well-being, Sexual Well-being, and Physical Well-being scales within the BREAST-Q Mastectomy, Breast Conserving Therapy, and Reconstruction modules. These normative scores will be useful in direct clinical care, research, and health policy. Furthermore, these normative values were generated from a large patient sample of over 1200 women with a diversity of age, bra cup size, and body mass index, to match the diverse population of women undergoing breast cancer treatment and reconstruction.
Limitations of this study relate primarily to the population of women used to generate the normative data. The Army of Women population is primarily Caucasian and composed of women with higher than average levels of education and income. Although this is consistent with the demographics of the majority of the literature using the BREAST-Q, this is certainly not representative of all women in the United States who have been diagnosed with breast cancer. In addition, women completed the study online without study personnel confirming their eligibility. The authors did not screen patients individually for a history of breast cancer or breast surgery, and it is possible that some respondents failed to exclude themselves based on exclusion criteria, thus biasing the results. Also, we did not know the number of women enrolled in the Army of Women who met inclusion criteria at the time of our study. We therefore calculated our response rate of 87 percent based on the number of women who confirmed eligibility for the study. As it is possible that there were additional women in the Army of Women who met inclusion criteria and were not interested in participating, our response rate may be overestimated. Additional limitations relate to the use of the previously published data sets, including limited follow-up time and lack of preoperative data. Lastly, the published literature describing results in the mastectomy and breast conserving therapy population used the Reconstructive module, instead of the Mastectomy and Breast Conserving Therapy modules, which have slightly different postoperative scales.
The normative values for the BREAST-Q generated here have significant implications for future research and clinical care. As discussed above, the ability to compare BREAST-Q scores with the norm helps to demonstrate the significance of a given difference in BREAST-Q scores between different patient populations. Normative values also contribute to our understanding of the impact of breast cancer and breast reconstruction on individuals. One example of this is the impact breast cancer and reconstruction has on physical well-being of the chest. This deviation from the norm would not have been appreciated without a normative reference point.
CONCluSIONS
Outcomes in patients undergoing breast cancer treatment and reconstruction are often evaluated with patient-reported outcome instruments, such as the BREAST-Q. Patient-reported outcome instruments generate useful data regarding breast satisfaction and breast-related quality of life. This study presents the first known normative values for the BREAST-Q. These normative scores will be useful for clinicians and researchers in providing a clinical context to interpret BREAST-Q data. 
